[18F] PBR111

DRUG2 trials

Sponsors

Institute for Neurodegenerative Disorders, University of North Carolina, Chapel Hill

Conditions

Alzheimer DiseaseConcussion, Brain

Phase 1

Evaluation of [18F] PBR111 and PET as a Marker of Inflammation in Subjects With Neurological Conditions

CompletedNCT01209156

Institute for Neurodegenerative DisordersAlzheimer Disease

Start: 2010-03-31End: 2013-06-30Updated: 2013-11-11

NFL LONG Prospective Study

Active, not recruitingNCT04263337

University of North Carolina, Chapel HillConcussion, Brain

Start: 2020-03-12End: 2028-08-01Target: 250Updated: 2026-04-22